Industries > Pharma > Aesthetic Medicine Market Report to 2031
Aesthetic Medicine Market Report to 2031
Forecasts By Product (Invasive Procedures (Breast augmentation, Liposuction, Nose reshaping, Eyelid Surgery, Tummy tuck, and others) Non-invasive Procedures (Botox injections, Soft tissue fillers, Chemical peel, Laser hair removal, Microdermabrasion, and Others) PLUS COVID-19 Recovery Scenarios
Aesthetic Medicine Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Aesthetic Medicine market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Aesthetic Medicine Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Aesthetic Medicine Market: By Product
• Invasive Procedures
o Breast augmentation
o Liposuction
o Nose reshaping
o Eyelid Surgery
o Tummy tuck
o Others
• Non-invasive Procedures
o Botox injections
o Soft tissue fillers
o Chemical peel
o Laser hair removal
o Microdermabrasion
o Others
Aesthetic Medicine Market: End User
• Clinics, Hospitals, and Medical Spas
• Beauty Centers
• Home Care
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Aesthetic Medicine Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Aesthetic Medicine Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Aesthetic Medicine Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Aesthetic Medicine Market, with forecasts for Product and End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Aesthetic Medicine market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Aesthetic Medicine Market. Some of the company’s profiled in this report include Allergan-AbbVie, Alma Lasers, Ltd., Anika Therapeutics, Cutera, Inc., Cynosure, El.En. S.p.A., Fotona d.o.o., Galderma, Johnson & Johnson, and Merz Pharma GmbH & Co. KGaA.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Aesthetic Medicine Market Report to 2031: Forecasts By Product (Invasive Procedures (Breast augmentation, Liposuction, Nose reshaping, Eyelid Surgery, Tummy tuck, and others) Non-invasive Procedures (Botox injections, Soft tissue fillers, Chemical peel, Laser hair removal, Microdermabrasion, and Others) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Aesthetic Medicine Market
2.1. Aesthetic Medicine Market Definition
2.2. Product Submarkets Definitions
2.3. End User Submarkets Definitions
3. Aesthetic Medicine Market Overview
3.1. Global Aesthetic Medicine Market Size and Forecast by Region
3.2. Global Aesthetic Medicine Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing adoption of minimally invasive and noninvasive aesthetic procedures
3.3.1.2. Rising adoption of aesthetic procedures among geriatric individuals
3.3.1.3. Availability of technologically advanced and user-friendly products
3.3.1.4. Increasing demand for aesthetic treatments among men
3.3.2. Market Restraints/Challenges
3.3.2.1. Clinical risks and complications associated with medical aesthetic procedures
3.3.2.2. Increasing availability and adoption of alternative beauty and cosmetic products
3.3.2.3. Social and ethical issues associated with cosmetic treatments
3.3.3. Opportunities
3.3.3.1. Emerging markets
3.3.3.2. Growing adoption of home-use aesthetic devices
3.3.3.3. Increasing disposable incomes and the expanding middle-class population
3.3.4. Global Aesthetic Medicine Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Aesthetic Medicine Market Analysis and Forecast 2021-2031, by Product (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Invasive Procedures
4.1.1.1. Breast augmentation
4.1.1.2. Liposuction
4.1.1.3. Nose reshaping
4.1.1.4. Eyelid Surgery
4.1.1.5. Tummy tuck
4.1.1.6. Others
4.1.2. Non-invasive Procedures
4.1.2.1. Botox injections
4.1.2.2. Soft tissue fillers
4.1.2.3. Chemical peel
4.1.2.4. Laser hair removal
4.1.2.5. Microdermabrasion
4.1.2.6. Others
5. Global Aesthetic Medicine Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Clinics, Hospitals, and Medical Spas
5.1.2. Beauty Centers
5.1.3. Home Care
6. North America Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Aesthetic Medicine Market Size and Forecast by Product
6.3. North America Aesthetic Medicine Market Size and Forecast by End User
6.4. U.S. Aesthetic Medicine Market
6.5. Canada Aesthetic Medicine Market
7. Europe Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Aesthetic Medicine Market Size and Forecast by Product
7.3. Europe Aesthetic Medicine Market Size and Forecast by End User
7.4. UK Aesthetic Medicine Market
7.5. Germany Aesthetic Medicine Market
7.6. France Aesthetic Medicine Market
7.7. Rest of Europe Aesthetic Medicine Market
8. Asia Pacific Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Aesthetic Medicine Market Size and Forecast by Product
8.3. Asia Pacific Aesthetic Medicine Market Size and Forecast by End User
8.4. China Aesthetic Medicine Market
8.5. India Aesthetic Medicine Market
8.6. Japan Aesthetic Medicine Market
8.7. Rest of Asia Pacific Aesthetic Medicine Market
9. Latin America Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Aesthetic Medicine Market Size and Forecast by Product
9.3. Latin America Aesthetic Medicine Market Size and Forecast by End User
9.3.1. Brazil Aesthetic Medicine Market
9.3.2. Mexico Aesthetic Medicine Market
9.3.3. Rest of Latin America Aesthetic Medicine Market
10. MEA Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Aesthetic Medicine Market Size and Forecast by Product
10.3. MEA Aesthetic Medicine Market Size and Forecast by End User
10.4. GCC Aesthetic Medicine Market
10.5. South Africa Aesthetic Medicine Market
10.6. Rest of MEA Aesthetic Medicine Market
11. Companies in the Aesthetic Medicine Market
11.1. Allergan-AbbVie
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Alma Lasers, Ltd.
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. Anika Therapeutics
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2019)
11.4. Cutera, Inc.
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2019)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2019
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2019)
11.5. Cynosure
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2019)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2019
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2019)
11.6. El.En. S.p.A.
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2019)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2019
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2019)
11.7. Fotona d.o.o.
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2019)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2019
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2019)
11.8. Galderma
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2019)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2019
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2019)
11.9. Johnson & Johnson
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2019)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2019
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2019)
11.10. Merz Pharma GmbH & Co. KGaA
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2019)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2019
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2019)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Aesthetic Medicine Market Drivers & Restraints 2020
Table 7 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 43 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 47 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Leading 10 Aesthetic Medicine Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 173 Allergan-AbbVie Profile 2019 (CEO, HQ, Founded, Website)
Table 174 Allergan-AbbVie Aesthetic Medicine Selected Recent Contracts 2019 (Date, Contract Product, Details)
Table 175 Allergan-AbbVie Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 176 Alma Lasers, Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 177 Alma Lasers, Ltd. Aesthetic Medicine Selected Recent Contracts 2017-2019 (Date, Contract Product, Details)
Table 178 Alma Lasers, Ltd. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 179 Anika Therapeutics Profile 2019 (CEO, HQ, Founded, Website)
Table 180 Anika Therapeutics Aesthetic Medicine Selected Recent Contracts 2017-2019 (Date, Contract Product, Details)
Table 181 Anika Therapeutics Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 182 Cutera, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 183 Cutera, Inc. Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 184 Cutera, Inc. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 185 Cynosure Profile 2019 (CEO, HQ, Founded, Website)
Table 186 Cynosure Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 187 Cynosure Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 188 El.En. S.p.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 189 El.En. S.p.A. Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 190 El.En. S.p.A. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 191 Fotona d.o.o. Profile 2019 (CEO, HQ, Founded, Website)
Table 192 Fotona d.o.o. Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 193 Fotona d.o.o. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 194 Galderma Profile 2019 (CEO, HQ, Founded, Website)
Table 195 Galderma Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 196 Galderma Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 197 Johnson & Johnson Profile 2019 (CEO, HQ, Founded, Website)
Table 198 Johnson & Johnson Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 199 Johnson & Johnson Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 200 Merz Pharma GmbH & Co. KGaA Profile 2019 (CEO, HQ, Founded, Website)
Table 201 Merz Pharma GmbH & Co. KGaA Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 202 Merz Pharma GmbH & Co. KGaA Aesthetic Medicine Product Offering (Segment, Product Offerings)
LIST OF FIGURES
Figure 1 Aesthetic Medicine Market Product Overview
Figure 2 Aesthetic Medicine Market End User Overview
Figure 3 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 4 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 5 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 6 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 7 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 8 Aesthetic Medicine Market Drivers & Restraints 2020
Figure 9 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 45 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 50 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 55 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 60 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 65 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 70 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 75 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Aesthetic Medicine Market
2.1. Aesthetic Medicine Market Definition
2.2. Product Submarkets Definitions
2.3. End User Submarkets Definitions
3. Aesthetic Medicine Market Overview
3.1. Global Aesthetic Medicine Market Size and Forecast by Region
3.2. Global Aesthetic Medicine Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing adoption of minimally invasive and noninvasive aesthetic procedures
3.3.1.2. Rising adoption of aesthetic procedures among geriatric individuals
3.3.1.3. Availability of technologically advanced and user-friendly products
3.3.1.4. Increasing demand for aesthetic treatments among men
3.3.2. Market Restraints/Challenges
3.3.2.1. Clinical risks and complications associated with medical aesthetic procedures
3.3.2.2. Increasing availability and adoption of alternative beauty and cosmetic products
3.3.2.3. Social and ethical issues associated with cosmetic treatments
3.3.3. Opportunities
3.3.3.1. Emerging markets
3.3.3.2. Growing adoption of home-use aesthetic devices
3.3.3.3. Increasing disposable incomes and the expanding middle-class population
3.3.4. Global Aesthetic Medicine Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Aesthetic Medicine Market Analysis and Forecast 2021-2031, by Product (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Invasive Procedures
4.1.1.1. Breast augmentation
4.1.1.2. Liposuction
4.1.1.3. Nose reshaping
4.1.1.4. Eyelid Surgery
4.1.1.5. Tummy tuck
4.1.1.6. Others
4.1.2. Non-invasive Procedures
4.1.2.1. Botox injections
4.1.2.2. Soft tissue fillers
4.1.2.3. Chemical peel
4.1.2.4. Laser hair removal
4.1.2.5. Microdermabrasion
4.1.2.6. Others
5. Global Aesthetic Medicine Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Clinics, Hospitals, and Medical Spas
5.1.2. Beauty Centers
5.1.3. Home Care
6. North America Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Aesthetic Medicine Market Size and Forecast by Product
6.3. North America Aesthetic Medicine Market Size and Forecast by End User
6.4. U.S. Aesthetic Medicine Market
6.5. Canada Aesthetic Medicine Market
7. Europe Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Aesthetic Medicine Market Size and Forecast by Product
7.3. Europe Aesthetic Medicine Market Size and Forecast by End User
7.4. UK Aesthetic Medicine Market
7.5. Germany Aesthetic Medicine Market
7.6. France Aesthetic Medicine Market
7.7. Rest of Europe Aesthetic Medicine Market
8. Asia Pacific Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Aesthetic Medicine Market Size and Forecast by Product
8.3. Asia Pacific Aesthetic Medicine Market Size and Forecast by End User
8.4. China Aesthetic Medicine Market
8.5. India Aesthetic Medicine Market
8.6. Japan Aesthetic Medicine Market
8.7. Rest of Asia Pacific Aesthetic Medicine Market
9. Latin America Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Aesthetic Medicine Market Size and Forecast by Product
9.3. Latin America Aesthetic Medicine Market Size and Forecast by End User
9.3.1. Brazil Aesthetic Medicine Market
9.3.2. Mexico Aesthetic Medicine Market
9.3.3. Rest of Latin America Aesthetic Medicine Market
10. MEA Aesthetic Medicine Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Aesthetic Medicine Market Size and Forecast by Product
10.3. MEA Aesthetic Medicine Market Size and Forecast by End User
10.4. GCC Aesthetic Medicine Market
10.5. South Africa Aesthetic Medicine Market
10.6. Rest of MEA Aesthetic Medicine Market
11. Companies in the Aesthetic Medicine Market
11.1. Allergan-AbbVie
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Alma Lasers, Ltd.
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. Anika Therapeutics
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2019)
11.4. Cutera, Inc.
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2019)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2019
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2019)
11.5. Cynosure
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2019)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2019
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2019)
11.6. El.En. S.p.A.
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2019)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2019
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2019)
11.7. Fotona d.o.o.
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2019)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2019
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2019)
11.8. Galderma
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2019)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2019
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2019)
11.9. Johnson & Johnson
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2019)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2019
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2019)
11.10. Merz Pharma GmbH & Co. KGaA
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2019)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2019
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2019)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Aesthetic Medicine Market Drivers & Restraints 2020
Table 7 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 43 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 47 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Leading 10 Aesthetic Medicine Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 173 Allergan-AbbVie Profile 2019 (CEO, HQ, Founded, Website)
Table 174 Allergan-AbbVie Aesthetic Medicine Selected Recent Contracts 2019 (Date, Contract Product, Details)
Table 175 Allergan-AbbVie Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 176 Alma Lasers, Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 177 Alma Lasers, Ltd. Aesthetic Medicine Selected Recent Contracts 2017-2019 (Date, Contract Product, Details)
Table 178 Alma Lasers, Ltd. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 179 Anika Therapeutics Profile 2019 (CEO, HQ, Founded, Website)
Table 180 Anika Therapeutics Aesthetic Medicine Selected Recent Contracts 2017-2019 (Date, Contract Product, Details)
Table 181 Anika Therapeutics Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 182 Cutera, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 183 Cutera, Inc. Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 184 Cutera, Inc. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 185 Cynosure Profile 2019 (CEO, HQ, Founded, Website)
Table 186 Cynosure Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 187 Cynosure Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 188 El.En. S.p.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 189 El.En. S.p.A. Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 190 El.En. S.p.A. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 191 Fotona d.o.o. Profile 2019 (CEO, HQ, Founded, Website)
Table 192 Fotona d.o.o. Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 193 Fotona d.o.o. Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 194 Galderma Profile 2019 (CEO, HQ, Founded, Website)
Table 195 Galderma Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 196 Galderma Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 197 Johnson & Johnson Profile 2019 (CEO, HQ, Founded, Website)
Table 198 Johnson & Johnson Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 199 Johnson & Johnson Aesthetic Medicine Product Offering (Segment, Product Offerings)
Table 200 Merz Pharma GmbH & Co. KGaA Profile 2019 (CEO, HQ, Founded, Website)
Table 201 Merz Pharma GmbH & Co. KGaA Aesthetic Medicine Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 202 Merz Pharma GmbH & Co. KGaA Aesthetic Medicine Product Offering (Segment, Product Offerings)
LIST OF FIGURES
Figure 1 Aesthetic Medicine Market Product Overview
Figure 2 Aesthetic Medicine Market End User Overview
Figure 3 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 4 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 5 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 6 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 7 Aesthetic Medicine Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 8 Aesthetic Medicine Market Drivers & Restraints 2020
Figure 9 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13 Aesthetic Medicine Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18 Invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Non-invasive Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Aesthetic Medicine Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Clinics, Hospitals, and Medical Spas Aesthetic Medicine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Beauty Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Home Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 45 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Regional Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 50 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 North America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 55 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 North America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 60 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 North America Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 65 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 US Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 70 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Canada Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 75 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 Europe Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 Europe Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 Europe Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 UK Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 Germany Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 France Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 Rest of Europe Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Asia Pacific Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Asia Pacific Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Asia Pacific Aesthetic Medicine Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 China Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 India Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 Japan Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 RoAPAC Aesthetic Medicine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 Middle East Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Middle East Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Latin America Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Latin America Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 Africa Aesthetic Medicine Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Africa Aesthetic Medicine Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Companies Profiled in the Report
1. Allergan-AbbVie
2. Alma Lasers, Ltd.
3. Anika Therapeutics
4. Cutera, Inc.
5. Cynosure
6. El.En. S.p.A.
7. Fotona d.o.o.
8. Galderma
9. Johnson & Johnson
10. Merz Pharma GmbH & Co. KGaA
List of Companies Mentioned in the Report:
1. Medytox, Inc.
2. Sientra, Inc.
3. Sinclair Pharma PLC
4. Syneron Medical, Ltd. (US
5. Baush Haealth (US)
6. Merck & Co. (MSD)
7. Eli Lilly
8. Astrazeneca
9. Teva
10. CR Pharmaceutical
11. Bristol-Myers Squibb
12. Merck (KGaA)
13. Novo Nordisk
14. Takeda
15. Allergan
16. Astellas Pharma
17. Mylan
18. Otsuka
19. Daiichi Sankyo
20. Valeant Pharmaceuticals
21. UCB
22. Zoetis
23. Eisai
24. Chugai Pharmaceutical
25. Perrigo
26. Sun Pharmaceutical
27. Mitsubishi Tanabe Pharma
28. Sichuan Languang Development
29. Sumitomo Dainippon Pharma
30. Yunnan Baiyao
31. Aspen Pharmacare
32. Endo
33. Kangmei Pharmaceutical
34. Galenica
35. Guangzhou Baiyunshan Pharmaceutical
36. Kyowa Hakko Kirin
37. Mallinckrodt
38. Shionogi & Co.
39. Shanghai Fosun Pharmaceutical
40. Stada Arzneimittel
41. Lundbeck
42. Zhejiang International
43. Lupin
44. Taisho Pharmaceutical
45. Tasly Pharmaceutical
46. Ipsen
47. Sino Biopharmaceutical
48. Ono Pharmaceutical
49. Aurobindo
50. Cipla
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
1. Allergan-AbbVie
2. Alma Lasers, Ltd.
3. Anika Therapeutics
4. Cutera, Inc.
5. Cynosure
6. El.En. S.p.A.
7. Fotona d.o.o.
8. Galderma
9. Johnson & Johnson
10. Merz Pharma GmbH & Co. KGaA
List of Companies Mentioned in the Report:
1. Medytox, Inc.
2. Sientra, Inc.
3. Sinclair Pharma PLC
4. Syneron Medical, Ltd. (US
5. Baush Haealth (US)
6. Merck & Co. (MSD)
7. Eli Lilly
8. Astrazeneca
9. Teva
10. CR Pharmaceutical
11. Bristol-Myers Squibb
12. Merck (KGaA)
13. Novo Nordisk
14. Takeda
15. Allergan
16. Astellas Pharma
17. Mylan
18. Otsuka
19. Daiichi Sankyo
20. Valeant Pharmaceuticals
21. UCB
22. Zoetis
23. Eisai
24. Chugai Pharmaceutical
25. Perrigo
26. Sun Pharmaceutical
27. Mitsubishi Tanabe Pharma
28. Sichuan Languang Development
29. Sumitomo Dainippon Pharma
30. Yunnan Baiyao
31. Aspen Pharmacare
32. Endo
33. Kangmei Pharmaceutical
34. Galenica
35. Guangzhou Baiyunshan Pharmaceutical
36. Kyowa Hakko Kirin
37. Mallinckrodt
38. Shionogi & Co.
39. Shanghai Fosun Pharmaceutical
40. Stada Arzneimittel
41. Lundbeck
42. Zhejiang International
43. Lupin
44. Taisho Pharmaceutical
45. Tasly Pharmaceutical
46. Ipsen
47. Sino Biopharmaceutical
48. Ono Pharmaceutical
49. Aurobindo
50. Cipla
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
Download sample pages
Complete the form below to download your free sample pages for Aesthetic Medicine Market Report to 2031Related reports
Advanced Wound Care Management Market Report to 2031
The occurrence of chronic and surgical wounds has amplified considerably in the past decade, mainly owing to the increasing old...Full DetailsPublished: 01 January 1970Aesthetic Lasers Market Report to 2031
The growing significance of physical looks is the key factor persuading people to shift towards minimally invasive aesthetic treatments, such...Full DetailsPublished: 01 January 1970Airway Management Devices Market Report to 2031
The growing occurrence of respiratory diseases is expected to have a high impact on the target industry growth....Full DetailsPublished: 01 January 1970Ambulance and Emergency Equipment Market Report to 2031
Rising incidence and prevalence of cardiovascular diseases, osteoarthritis disorder, and multiple cancer require emergency medical response support to save lives...Full DetailsPublished: 01 January 1970Aesthetic Lasers and Energy Devices Market Report to 2031
The growing significance of physical looks is the key factor persuading people to shift towards minimally invasive aesthetic treatments, such...Full DetailsPublished: 01 January 1970Angioplasty Balloons Market Report to 2031
The occurrence of chronic disorders is expected to surge in the coming years. Furthermore, the increasing geriatric population suffering from...Full DetailsPublished: 01 January 1970Amniotic Membrane Market Report to 2031
The rising cases of hazardous trauma, burn and trends of surgical cures, and increasing awareness of amniotic membrane product advantages...Full DetailsPublished: 01 January 1970Aortic Aneurysm Market Report 2021-2031
The growth in the market can be attributed to the high tobacco smoking prevalence in the developed and developing region,...Full DetailsPublished: 21 April 2021
Download sample pages
Complete the form below to download your free sample pages for Aesthetic Medicine Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
